Skip to main content
. 2011 Nov 9;103(1):125–130. doi: 10.1111/j.1349-7006.2011.02120.x

Figure 1.

Figure 1

 Median serum levels of daidzein in Japanese men given oral isoflavone (60 mg/day) or placebo for 12 months (n = 158). Daidzein was significantly increased in the isoflavone groups, and its level was lower in individuals who could also degrade daidzein into equol (isoflavone/producer group) compared with those who could not (isoflavone/non‐producer group).